Accuracy of rapid and point-of-care screening tests for hepatitis C: A systematic review and meta-analysis

Annals of Internal Medicine

Volumn 157, Issue 8, 2012, Pages 558-566

  Shivkumar, Sushmita ^a   Peeling, Rosanna ^b   Jafari, Yalda ^a   Joseph, Lawrence ^c   Pai, Nitika Pant ^d  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

^d ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD ANALYSIS; CHEMILUMINESCENCE IMMUNOASSAY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HUMAN; META ANALYSIS; MICROPARTICLE ENZYME IMMUNOASSAY; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAPID TEST; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

EID: 84868333689     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-157-8-201210160-00006     Document Type: Review

References (38)

1. Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3:47-52. [PMID: 16614742]
2. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5:558-67. [PMID: 16122679]
3. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44:S6-9. [PMID: 16352363]
4. Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada. I-Track: Enhanced Surveillance of Risk Behaviours Among People who Inject Drugs. Phase I report, August 2006. Ottawa, Ontario, Canada: Public Health Agency of Canada, 2006.
5. Nyirenda M, Beadsworth MB, Stephany P, Hart CA, Hart IJ, Munthali C, et al. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. J Infect. 2008;57:72-7. [PMID:18555534]
6. Ivantes CA, Silva D, Messias-Reason I. High prevalence of hepatitis C associated with familial history of hepatitis in a small town of south Brazil: efficiency of the rapid test for epidemiological survey. Braz J Infect Dis. 2010;14:483-8. [PMID: 21221477]
7. Hui AY, Chan FK, Chan PK, Tam JS, Sung JJ. Evaluation of a new rapid whole-blood serological test for hepatitis c virus [Letter]. Acta Virol. 2002;46: 47-8. [PMID: 12197634]
8. Tedaldi EM, Baker RK, Moorman AC, Alzola CF, Furhrer J, McCabe RE, et al; HIV Outpatient Study (HOPS) Investigators. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2003;36:363-7. [PMID: 12539079]
9. Nelson DR. Hepatitis C drug development at a crossroads [Editorial]. Hepatology. 2009;50:997-9. [PMID: 19787813]
10. Downing M, Knight K, Reiss TH, Vernon K, Mulia N, Ferreboeuf M, et al. Drug users talk about HIV testing: motivating and deterring factors. AIDS Care. 2001;13:561-77. [PMID: 11571004]
11. Drobnik A, Judd C, Banach D, Egger J, Konty K, Rude E. Public health implications of rapid hepatitis C screening with an oral swab for communitybased organizations serving high-risk populations. Am J Public Health. 2011;101: 2151-5. [PMID: 21940910]
12. Alter MJ, Kuhnert WL, Finelli L; Centers for Disease Control and Prevention. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003;52(RR-3):1-13, 15; quiz CE1-4. [PMID: 12585742]
13. Mabey D, Peeling RW, Perkins MD. Rapid and simple point of care diagnostics for STIs [Editorial]. Sex Transm Infect. 2001;77:397-8. [PMID:11714933]
14. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529-36. [PMID:22007046]
15. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al; Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med. 2003;138:40-4. [PMID: 12513043]
16. Harbord RM, Whiting P. Meta-analysis of diagnostic accuracy. In: Sterne JA, ed. Meta-analysis in Stata: An Updated Collection From the Stata Journal. College Station, TX: Stata Pr; 2009.
17. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994;271:703-7. [PMID: 8309035]
18. Torane VP, Shastri JS. Comparison of ELISA and rapid screening tests for the diagnosis of HIV, hepatitis B and hepatitis C among healthy blood donors in a tertiary care hospital in Mumbai [Letter]. Indian J Med Microbiol. 2008;26: 284-5. [PMID: 18695340]
19. Smith BD, Drobeniuc J, Jewett A, Branson BM, Garfein RS, Teshale E, et al. Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. J Infect Dis. 2011;204:825-31. [PMID: 21849279]
20. Smith BD, Teshale E, Jewett A, Weinbaum CM, Neaigus A, Hagan H, et al. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites. Clin Infect Dis. 2011;53:780-6. [PMID: 21921221]
21. Lee SR, Yearwood GD, Guillon GB, Kurtz LA, Fischl M, Friel T, et al. Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection. J Clin Virol. 2010;48:15-7. [PMID: 20362493]
22. Lee SR, Kardos KW, Schiff E, Berne CA, Mounzer K, Banks AT, et al. Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid. J Virol Methods. 2011;172:27-31. [PMID: 21182871]
23. Department of Blood Safety and Clinical Technology. Hepatitis C Assays: Operational Characteristics (Phase I) Report 1. Geneva: World Health Organization; 2001.
24. Department of Blood Safety and Clinical Technology. Hepatitis C Assays: Operational Characteristics (Phase I) Report 2. Geneva: World Health Organization; 2001.
25. Department of Blood Safety and Clinical Technology. WHO Evaluation (Phase 1) of SDHCV Bioline [draft report]. Geneva: World Health Organization; 2002.
26. Njouom R, Tejiokem MC, Zanga MC, Pouillot R, Ayouba A, Pasquier C, et al. A cost-effective algorithm for the diagnosis of Hepatitis C virus infection and prediction of HCV viremia in Cameroon. J Virol Methods. 2006;133:223-6. [PMID: 16360220]
27. Daniel HD, Abraham P, Raghuraman S, Vivekanandan P, Subramaniam T, Sridharan G. Evaluation of a rapid assay as an alternative to conventional enzyme immunoassays for detection of hepatitis C virus-specific antibodies. J Clin Microbiol. 2005;43:1977-8. [PMID: 15815036]
28. Kaur H, Dhanao J, Oberoi A. Evaluation of rapid kits for detection of HIV, HBsAg and HCV infections. Indian J Med Sci. 2000;54:432-4. [PMID:11262859]
29. Mvere D, Constantine NT, Katsawde E, Tobaiwa O, Dambire S, Corcoran P. Rapid and simple hepatitis assays: encouraging results from a blood donor population in Zimbabwe. Bull World Health Organ. 1996;74:19-24. [PMID:8653812]
30. Yuen MF, Hui CK, Yuen JC, Young JL, Lai CL. The accuracy of SM-HCV rapid test for the detection of antibody to hepatitis C virus. Am J Gastroenterol. 2001;96:838-41. [PMID: 11280561]
31. Poovorawan Y, Theamboonlers A, Chumdermpadetsuk S, Thong CP. Comparative results in detection of HCV antibodies by using a rapid HCV test, ELISA and immunoblot. Southeast Asian J Trop Med Public Health. 1994;25: 647-9. [PMID: 7545315]
32. Montebugnoli L, Borea G, Miniero R, Sprovieri G. A rapid test for the visual detection of anti-hepatitis C virus antibodies in whole blood. Clin Chim Acta. 1999;288:91-6. [PMID: 10529461]
33. De Cock L, Hutse V, Verhaegen E, Quoilin S, Vandenberghe H, Vranckx R. Detection of HCV antibodies in oral fluid. J Virol Methods. 2004;122:179-83. [PMID: 15542142]
34. Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med. 2004;140:189-202. [PMID: 14757617]
35. Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010;59(RR-12):1-110. [PMID: 21160459]
36. Altman DG, Bland JM. Diagnostic tests 1: sensitivity and specificity. BMJ. 1994;308:1552. [PMID: 8019315]
37. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ. 2004;329: 168-9. [PMID: 15258077]
38. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56: 1129-35. [PMID: 14615004]